Matches in Nanopublications for { ?s ?p "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine." ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- _3 value "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine." provenance.
- _3 value "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine." provenance.
- _3 value "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine." provenance.
- _3 value "Treatment of A549 cells with 20 microM gemcitabine, cisplatin, or taxol or with 50 microM camptothecin caused robust PARP cleavage, which was inhibited by 1 M nicotine (Fig. 1d). Drug treatment enhanced the levels of p53 and its transcriptional target, p21, as seen by Western blots; interestingly, this induction was also inhibited by nicotine." provenance.